Clinical Efficacy of Cell Culture-Derived and Egg-Derived Inactivated Subunit Influenza. vaccines in Healthy AdultsFREY, Sharon; VESIKARI, Timo; SZYMCZAKIEWICZ-MULTANOWSKA, Agnieszka et al.Clinical infectious diseases. 2010, Vol 51, Num 9, pp 997-1004, issn 1058-4838, 8 p.Article

Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity and ImmunogenicityREISINGER, Keith S; BLOCK, Stanley L; IZU, Allen et al.The Journal of infectious diseases. 2009, Vol 200, Num 6, pp 849-857, issn 0022-1899, 9 p.Article

Influenza vaccine in healthy children : a meta-analysisNEGRI, Eva; COLOMBO, Carla; GIORDANO, Laura et al.Vaccine. 2005, Vol 23, Num 22, pp 2851-2861, issn 0264-410X, 11 p.Article

An early (3―6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria^® in a province of Emilia-Romagna region, Italy ― Part OneCANDELA, Silvia; PERGOLIZZI, Sara; RAGNI, Pietro et al.Vaccine. 2013, Vol 31, Num 10, pp 1431-1437, issn 0264-410X, 7 p.Article

A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccineAMBROZAITIS, Arvydas; GROTH, Nicola; BUGARINI, Roberto et al.Vaccine. 2009, Vol 27, Num 43, pp 6022-6029, issn 0264-410X, 8 p.Article

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety databasePELLEGRINI, Michele; NICOLAY, Uwe; LINDERT, Kelly et al.Vaccine. 2009, Vol 27, Num 49, pp 6959-6965, issn 0264-410X, 7 p.Article

Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern ItalyVILLA, Marco; BLACK, Steven; MALCHIODI, Giancarlo et al.American journal of epidemiology. 2013, Vol 178, Num 7, pp 1139-1145, issn 0002-9262, 7 p.Article

Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern ItalyMANNINO, Salvatore; VILLA, Marco; ROTHMAN, Kenneth J et al.American journal of epidemiology. 2012, Vol 176, Num 6, pp 527-533, issn 0002-9262, 7 p.Article

Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture-Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of AgeVESIKARI, Timo; BLOCK, Stan L; GUERRA, Fernando et al.The Pediatric infectious disease journal. 2012, Vol 31, Num 5, pp 494-500, issn 0891-3668, 7 p.Article

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trialKEITEL, Wendy; GROTH, Nicola; LATTANZI, Maria et al.Vaccine. 2010, Vol 28, Num 3, pp 840-848, issn 0264-410X, 9 p.Article

Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 AdjuvantVESIKARI, Timo; PELLEGRINI, Michele; KARVONEN, Aino et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 7, pp 563-571, issn 0891-3668, 9 p.Article

Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell CultureSZYMCZAKIEWICZ-MULTANOWSKA, Agnieszka; GROTH, Nicola; BUGARINI, Roberto et al.The Journal of infectious diseases. 2009, Vol 200, Num 6, pp 841-848, issn 0022-1899, 8 p.Article